In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


South Korea Resumes A/H1N1 Vaccine Talks With GSK, Novartis, Sanofi-Aventis, Baxter, CSL

This article was originally published in PharmAsia News

Executive Summary

SEOUL - One month after South Korea's Ministry for Health, Welfare and Family Affairs failed to select a company to provide A/H1N1 vaccines at what it considered a "reasonable price," the ministry reopened talks with Baxter International, GlaxoSmithKline, Novartis, CSL of Australia and Sanofi-Aventis to calm mounting public pressure to secure the vaccines

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts